Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
Clinical trial NCT04822337 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04822337
- Sponsor
- Wake Forest University Health Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-19
- Primary completion
- 2029-04-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.